Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
A major challenge in developing effective anti-cancer therapies is identifying tumor-specific properties
Dehydration is a common and often overlooked cause of fatigue
Cosentyx (secukinumab) Disease area(s): Immunology Manufacturer(s): Novartis 2024 Sales (USD): $6.14 billion Why it sold so well: In 2024, Novartis Cosentyx registered significant sales growth, with revenues increasing by 23% year-over-year to $6.14 billion
BPC-157 supports systemic regeneration by stimulating angiogenesis, improving microcirculation, and promoting fibroblast migration
US$ 28.23
US$ 21.86
US$ 25.08
US$ 28.33
US$ 22.13
US$ 26.74
US$ 21.47
